BOTUNUM TOXIN A PREVENTS THE DEVELOPMENT OF CONTRACTURES IN THE HEREDITARY SPASTC MOUSE
- 1 May 1994
- journal article
- research article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 36 (5) , 379-385
- https://doi.org/10.1111/j.1469-8749.1994.tb11863.x
Abstract
The hereditary spastic mouse was studied as a model of cerebral palsy in childhood to test the hypothesis that intramuscular botulinum toxin A would prevent the development of calf-muscle contractures. A prospective randomised controlled trial of calf injection with botulinum A compared with injection of normal saline was performed on juvenile mice. At maturity, the calf muscles of the spastic mice were 16 per cent shorter than those of their normal siblings. The calf muscles of spastic mice injected with botulinum toxin A grew to within 2 per cent of normal length. This difference in mature muscle length was highly significant.Keywords
This publication has 9 references indexed in Scilit:
- GABAA‐receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunitsJournal of Comparative Neurology, 1995
- Disorders of the inhibitory glycine receptor: the spastic mouseThe FASEB Journal, 1990
- Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type a toxin: Morphological and electrophysiological featuresNeuroscience, 1990
- MUSCLE GROWTH IN NORMAL AND SPASTIC MICEDevelopmental Medicine and Child Neurology, 1984
- Glycine receptor alteration in the mutant mouse spasticNature, 1982
- Electrophysiological studies with the spastic mutant mouseBrain Research, 1982
- Experimental rapid sarcomere loss with concomitant hypoextensibilityMuscle & Nerve, 1981
- Stretch-induced growth in chicken wing muscles: a new model of stretch hypertrophyAmerican Journal of Physiology-Cell Physiology, 1980
- HEREDITARY SPASTICITY IN MICEJournal of Heredity, 1961